Company Announcements

Holding(s) in Company

Source: RNS
RNS Number : 3563M
Clinigen Group plc
20 September 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B89J2419

Issuer Name

CLINIGEN GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Bank of America Corporation

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

MERRILL LYNCH INTERNATIONAL

London

United Kingdom

5. Date on which the threshold was crossed or reached

16-Sep-2021

6. Date on which Issuer notified

17-Sep-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.220457

3.948180

7.168637

9536342

Position of previous notification (if applicable)

2.165000

3.122000

5.287000


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B89J2419


4284131


3.220457

Sub Total 8.A

4284131

3.220457%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Right to recall

N/A

N/A

67043

0.050397

Sub Total 8.B1


67043

0.050397%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Swaps

29/04/2022

N/A

Cash

631887

0.475001

Swaps

13/05/2022

N/A

Cash

38465

0.028915

Swaps

08/07/2022

N/A

Cash

2340000

1.759020

Swaps

19/07/2022

N/A

Cash

1641258

1.233763

Swaps

29/07/2022

N/A

Cash

70206

0.052775

Swaps

21/09/2022

N/A

Cash

178708

0.134338

Swaps

10/11/2022

N/A

Cash

220

0.000165

Swaps

16/11/2022

N/A

Cash

104356

0.078446

Swaps

15/02/2023

N/A

Cash

12852

0.009661

Swaps

28/02/2023

N/A

Cash

92854

0.069800

Swaps

02/07/2024

N/A

Cash

70261

0.052816

Swaps

15/09/2026

N/A

Cash

4101

0.003083

Sub Total 8.B2


5185168

3.897783%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Bank of America Corporation

Merrill Lynch International

3.220457


4.099967%

Bank of America Corporation

BOFA Securities EUROPE SA


3.042118

3.042118%

Bank of America Corporation

Bank of America, National Association




Bank of America Corporation

BofA Securities, Inc.




10. In case of proxy voting

Name of the proxy holder

No

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

17-Sep-2021

13. Place Of Completion

United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALNEADPFEFA